The extracellular chaperone clusterin potently inhibits human lysozyme amyloid formation by interacting with prefibrillar species.
We have studied the effects of the extracellular molecular chaperone, clusterin, on the in vitro aggregation of mutational variants of human lysozyme, including one associated with familial amyloid disease. The aggregation of the amyloidogenic variant I56T is inhibited significantly at clusterin to...
المؤلفون الرئيسيون: | Kumita, JR, Poon, S, Caddy, G, Hagan, C, Dumoulin, M, Yerbury, J, Stewart, E, Robinson, C, Wilson, MR, Dobson, C |
---|---|
التنسيق: | Journal article |
اللغة: | English |
منشور في: |
2007
|
مواد مشابهة
-
Rationalising lysozyme amyloidosis: insights from the structure and solution dynamics of T70N lysozyme.
حسب: Johnson, R, وآخرون
منشور في: (2005) -
The extracellular chaperone Clusterin enhances Tau aggregate seeding in a cellular model
حسب: Patricia Yuste-Checa, وآخرون
منشور في: (2021-08-01) -
The significance of the location of mutations for the native-state dynamics of human lysozyme
حسب: Ahn, M, وآخرون
منشور في: (2016) -
The Extracellular Molecular Chaperone Clusterin Inhibits Amyloid Fibril Formation and Suppresses Cytotoxicity Associated with Semen-Derived Enhancer of Virus Infection (SEVI)
حسب: Abigail K. Elias, وآخرون
منشور في: (2022-10-01) -
Expression and purification of chaperone-active recombinant clusterin.
حسب: Rebecca A Dabbs, وآخرون
منشور في: (2014-01-01)